Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.

Italiano A, Cioffi A, Penel N, Levra MG, Delcambre C, Kalbacher E, Chevreau C, Bertucci F, Isambert N, Blay JY, Bui B, Antonescu C, D'Adamo DR, Maki RG, Keohan ML

Open source

DOI: 10.1002/cncr.26599
Published: 2012 Jul 1
Container: Cancer
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cncr.26599,
  title = {Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.},
  author = {Italiano A and Cioffi A and Penel N and Levra MG and Delcambre C and Kalbacher E and Chevreau C and Bertucci F and Isambert N and Blay JY and Bui B and Antonescu C and D'Adamo DR and Maki RG and Keohan ML},
  year = {2012},
  journal = {Cancer},
  doi = {10.1002/cncr.26599},
  url = {https://doi.org/10.1002/cncr.26599}
}

RIS

TY  - JOUR
TI  - Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
AU  - Italiano A
AU  - Cioffi A
AU  - Penel N
AU  - Levra MG
AU  - Delcambre C
AU  - Kalbacher E
AU  - Chevreau C
AU  - Bertucci F
AU  - Isambert N
AU  - Blay JY
AU  - Bui B
AU  - Antonescu C
AU  - D'Adamo DR
AU  - Maki RG
AU  - Keohan ML
PY  - 2012
JO  - Cancer
DO  - 10.1002/cncr.26599
UR  - https://doi.org/10.1002/cncr.26599
ER  -

APA

A, I., A, C., N, P., MG, L., C, D., E, K., C, C., F, B., N, I., JY, B., B, B., C, A., DR, D., RG, M., & ML, K. (2012). Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.. Cancer. https://doi.org/10.1002/cncr.26599

Source records

pubmed · retrieved 2026-11-10T08:27:27.662Z
europe-pmc · retrieved 2026-11-10T08:27:27.692Z
hal · retrieved 2026-11-10T08:27:27.749Z